Presentation
Prostate-specific antigen level of 5.41 ng/mL and a new diagnosis of intermediate-risk prostate cancer.
Patient Data
| Age: | 70 years |
|---|---|
| Gender: | Male |
Prostate-specific antigen level of 5.41 ng/mL and a new diagnosis of intermediate-risk prostate cancer.
| Age: | 70 years |
|---|---|
| Gender: | Male |